NCT03029988 2020-09-10
An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
Navidea Biopharmaceuticals
Phase 1 Terminated
Clinical Trials
1 trialsTerminated × Adenocarcinoma × technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran × Clear all